- Projects & figures
- News & Events
- Managing your project
- About ERC
Radio astronomy has now entered a “golden age” with new facilities paving the way for significant discoveries on the early universe and the formation and evolution of galaxies. Working on faint radio-signals, Dr Vernesa Smolčić’s research may lead to significant advances in the area. Her goal is to provide the first census of high-redshift star-bursting galaxies, also called “submillimetre galaxies”, and a full census of galaxies hosting supermassive black holes.
In only three years’ time, Dr Jan Tkač went from being the first ERC grantee in Slovakia to obtaining the “2015 Scientist of the Year” award. His research in the field of glyconomics could emerge as a turning point for the diagnosis of cell-related diseases.
Vaccination has achieved huge success in controlling many devastating infectious diseases. However, there are still many such diseases, or ‘pathogens’, against which we cannot generate life-long protective immunity. On the eve of Croatia’s accession to the EU, Professor Stipan Jonjic’s ERC-funded research into new vaccines to offer better protection– is already underway. Prof Jonjic is the first Croatian ERC grantee to base his project in Croatia.
In Bratislava, the team of Dr Ján Tkáč is developing the weapons to fight back in a cellular ‘cold war’ by using new early-detection technologies – helped by the first ERC grant awarded in Slovakia. Glycans are sugar molecules that carry the information human cells need to stay healthy and fight infections. Information rich, and with sophisticated storage and coding commands, they are a vital early-warning system for triggering an organism’s natural defensive systems at the first sign of attack. So it is not surprising that infectious pathogens such as bacteria and viruses, and cell-related diseases such as cancers, have developed subterfuges to bypass this first line of defence. For example, HIV viruses do this by cracking the glycan’s molecular code, and stealing its identity – allowing the pathogen to go unrecognised by cells until the infection is well advanced.